<?xml version="1.0" encoding="UTF-8"?>
<fig id="ppat.1006835.g007" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.ppat.1006835.g007</object-id>
 <label>Fig 7</label>
 <caption>
  <title>RRV-YF is attenuated 
   <italic>in vivo</italic>.
  </title>
  <p>Disease scores (
   <bold>A</bold>) and weights (
   <bold>B</bold>) of twenty day old C57BL/6 wt mice injected subcutaneously with 10
   <sup>4</sup> pfu of RRV-wt or RRV-YF or mock-infected with PBS. 
   <bold>C.</bold> Representative histology images (hematoxylin-eosin staining) of quadriceps at 10 days p.i. Scale bar: 100 μm Virus titres from tail blood (
   <bold>D</bold>), spleen, quadricep, and ankle (
   <bold>E</bold>) at different time points after infection, determined by plaque assay. Data are presented as mean ± SEM of 3–4 mice per group. Statistical significance for the difference between RRV-wt- and RRV-YF-infected mice was determined using two-way ANOVA with Bonferroni post-test (B, D, and E) or non-parametric Mann–Whitney test (A). 0.05&gt; p &lt; 0.01; ** 0.01&gt; p &lt; 0.001; *** p &lt; 0.001.
  </p>
 </caption>
 <graphic xlink:href="ppat.1006835.g007" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
